Filing metadata

Accession number
0001415889-25-016726
Form type
Form 3
Filer
Lyell Immunopharma, Inc.
CIK
CIK 1806952
Filed
Jun 11, 2025
Reporting period
Jun 09, 2025
Description
Initial ownership

Explore SEC Filings Hub